Ipca Laboratories profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| 15.2% | 15.2% | 11.1% | 9.0% | 8.3% | ||
| 9.8% | 9.8% | 6.9% | 5.3% | 5.9% | ||
| 16.1% | 16.1% | 14.7% | 12.4% | 10.2% | ||
| 15.0% | 12.9% | 10.6% | 7.3% | 7.6% | ||
Margins | ||||||
| 22.0% | 20.5% | 19.3% | 17.2% | 14.8% | ||
| 16.2% | 16.2% | 14.9% | 12.5% | 10.7% | ||
| — | 32.8% | 29.5% | 20.4% | — | ||
| 17.9% | 16.3% | 12.7% | 10.9% | 11.9% | ||
| 13.6% | 12.3% | 8.8% | 6.8% | 7.7% | ||
| 12.9% | 11.8% | 8.3% | 7.1% | 7.5% | ||
| 5.1% | 5.1% | 6.1% | 6.9% | 5.0% | ||
Additional | ||||||
| 23.9% | 24.2% | 30.4% | 37.2% | 34.0% | ||
| — | 4.4% | 12.9% | 9.7% | 21.2% | ||
| 15.2% | 14.5% | 9.7% | 8.1% | 6.6% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.